Virtual specialty care platform AmplifyMD, which aims to help hospitals do more with fewer doctors, scored $20 million dollars this Wednesday in a Series B financing round led by Forerunner Ventures.
The FDA has approved a Novartis drug for chronic spontaneous urticaria (CSU), providing patients an oral treatment alternative to currently available injectable medications. The regulatory decision ...
The next phase of AI in healthcare is about building systems where human clinicians, supervisors, and AI can all contribute, ...
Elevance Health is leveraging AI for simplifying the member experience, improving the provider experience and making sure ...
The true promise of AI lies not in autonomy of either the clinician or machine, but in a balanced collaboration that bolsters ...
The healthcare affordability crisis in the U.S. has quietly become a trust crisis, with a growing share of Americans walking ...
The Digital Medicine Society launched an initiative to help payers and virtual care providers avoid common contract ...
The healthcare industry is spending more than ever on AI — but according to executives from Oracle Health, HCA Healthcare and ...
An OIG report found that the three largest Medicare Advantage insurers denied prior authorization requests for long-term ...
Insecurity about transportation can lead to missed appointments and delayed care, and obstacles are more common for cancer ...
During a panel at HFMA’s annual conference, two healthcare credit analysts said the industry is already fracturing into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results